-
-
-
-
-
-
-
AzurRx BioPharma (AZRX) Activates New Clinical Trial Sites in India for Phase 2 RESERVOIR Trial Evaluating Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
-
-
-
-
-
-
-
Pre-Open Stock Movers 08/18: (VRPX) (AZRX) (GLG) (TLRY) (LOW) (PLCE) (more...)
-
-
-
-
-
-
-
AzurRx BioPharma Completes Initial Cohort Enrollment into Part 1 of its RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections
-
-
-
-
-
-
-
AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital
-
-
-
-
-
-
-
AzurRx BioPharma to Present at Investor Summit Group’s Q2 Virtual Investor Summit (May 17)
-
-
-
-
-
-
-
AzurRx BioPharma Provides Key Takeaways from Phase 2b OPTION 2 Clinical Trial Topline Results Conference Call
-
-
-
-
-
-
-
AzurRx BioPharma to Present at the Maxim Group Emerging Growth Virtual Conference (March 17-18)
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

